1. FRI0004 Randomization to Patient-Reported RAPID3 versus Physician-Based CDAI Tools for Prediction of Treatment Response and Assessment of Patient-Reported Outcomes in Rheumatoid Arthritis Patients Receiving Certolizumab Pegol: Results from the PREDICT Study. (10th June 2014) Authors: Curtis, J.R.; Churchill, M.; Kivitz, A.; Samad, A.; Gauer, L.; Coteur, G.; Gervitz, L.; Koetse, W.; Melin, J.; Yazici, Y. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 382 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗